Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients

Wyeth

Status: Completed

Conditions: Depressive Syndrome; Anxiety

Study type: Observational

Funder types: Industry

Identifiers

NCT00247429

101356

Details and patient eligibility

About

In this study we will assess as a primary objective the effect of venlafaxine retard treatment on primary care attended elderly patients with depressive syndrome. We will also study secondarily its effects on anxiety, somatic and painful symptoms of depression.

Enrollment: 59 patients

Sex: All

Ages: 60+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients older than 60 years
• Depressive syndrome with associated anxiety symptoms, according to a symptoms intensity HAM-D17³14

Exclusion criteria

• Participation in other studies in the last 3 months before the start of the study
• Known hypersensibility to venlafaxine
• Clinically significant abnormalities according to the venlafaxine labeling